OSCR

Acetylcholine Receptor Antibody Positivity, RNST Abnormality, and Thymoma Predict Generalization in Ocular Myasthenia Gravis: A South Korean Cohort Study.

Overview

Authors: Hyun Jin Shin1,2,3, Chaerin Kwon1, Jeeyoung Oh1,3,4
  1. School of Medicine, Konkuk University, Chungju-si 27478, Republic of Korea; (H.J.S.); (C.K.)
  2. Department of Ophthalmology, Konkuk University Medical Center, Seoul 05030, Republic of Korea
  3. Research Institute of Medical Science, Konkuk University, Seoul 05029, Republic of Korea
  4. Department of Neurology, Konkuk University Medical Center, Seoul 05030, Republic of Korea
Institutions: Konkuk University (South Korea); Konkuk University Medical Center (South Korea)
Journal: Antibodies (Basel, Switzerland), volume 15, issue 4, article 73
Dates: received 17 June 2026; accepted 7 August 2026; published online 11 August 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.3390/antib15040073 · PMID 42645431 · PMCID PMC13509972 · OpenAlex W7202204029
Open access: gold, a free copy (OpenAlex)
Categories: human (organism), other condition (population), cellular / molecular (subfield)
Methods: Statistics, Physiology & signal measures
Keywords: ocular myasthenia gravis, generalized myasthenia gravis, acetylcholine receptor antibody, repetitive nerve stimulation test, thymoma
Topic: Myasthenia Gravis and Thymoma (Clinical Neurology, Medicine), according to OpenAlex
Funding: National Research Foundation of Korea (RS-2026-25489895); Korean government (MSIT) (RS-2026-25489895)
Citations: not cited yet (Europe PMC); 33 references in the paper

Abstract

Background: Ocular myasthenia gravis (OMG) can remain restricted to ocular symptoms or progress to generalized myasthenia gravis (GMG). However, the rate of generalization and its predictors may vary across populations, and data on South Korean patients remain inadequate. This study investigated the conversion rate from OMG to GMG and identified clinical, serologic, electrophysiologic, and thymic predictors of this generalization in a South Korean cohort. Methods: This retrospective cohort study included 89 patients who initially presented with OMG and were followed up for at least 2 years. The primary outcome was conversion to GMG during follow-up. The investigated predictors included demographic variables, initial ocular manifestations, acetylcholine receptor antibody (AChR-Ab) status and titer, repetitive nerve stimulation test (RNST) findings, thymic abnormalities, and immunosuppressive treatment. Kaplan–Meier analyses and Cox proportional-hazards models were used to evaluate the GMG-free survival rate and risk factors for conversion. Results: During follow-up, 10 patients (11.2%) progressed to GMG, with this conversion occurring within 2 years in 8 patients (9.0%). All converters were AChR-Ab positive. AChR-Ab positivity, RNST positivity, thymic abnormality, and thymoma were associated with GMG conversion in univariable analyses. RNST positivity in any tested muscle (hazard ratio [HR] = 12.66, 95% confidence interval [CI] = 2.68–59.76, p = 0.001) and thymoma (HR = 10.67, 95% CI = 3.06–37.27, p < 0.001) was associated with generalization. These associations persisted in the restricted multivariable Cox model. Conclusions: The rate of GMG conversion was relatively low in this South Korean OMG cohort, and most conversions occurred within 2 years. The presence of AChR-Ab positivity, RNST abnormality, or thymoma may characterize high-risk patients who require closer monitoring during the early disease course.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data and to no code of its authors: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data Availability Statement

The minimal anonymized dataset required to reproduce the findings of our study has been deposited in a public repository (Figshare) and is accessible via the following DOI: http://doi.org/10.6084/m9.figshare.32573280.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 3 authors, 5 keywords, 2 funders, 33 references.

Cite

This paper

Shin, H. J., Kwon, C., & Oh, J. (2026). Acetylcholine Receptor Antibody Positivity, RNST Abnormality, and Thymoma Predict Generalization in Ocular Myasthenia Gravis: A South Korean Cohort Study. Antibodies (Basel, Switzerland), 15(4), 73. https://doi.org/10.3390/antib15040073

BibTeX

@article{shin2026acetylcholine,
author = {Shin, Hyun Jin and Kwon, Chaerin and Oh, Jeeyoung},
title = {{Acetylcholine Receptor Antibody Positivity, RNST Abnormality, and Thymoma Predict Generalization in Ocular Myasthenia Gravis: A South Korean Cohort Study}},
journal = {Antibodies (Basel, Switzerland)},
year = {2026},
month = aug,
volume = {15},
number = {4},
pages = {73},
publisher = {Multidisciplinary Digital Publishing Institute (MDPI)},
issn = {2073-4468},
doi = {10.3390/antib15040073},
url = {https://doi.org/10.3390/antib15040073},
pmid = {42645431},
pmcid = {PMC13509972}
}

RIS

TY - JOUR
AU - Shin, Hyun Jin
AU - Kwon, Chaerin
AU - Oh, Jeeyoung
TI - Acetylcholine Receptor Antibody Positivity, RNST Abnormality, and Thymoma Predict Generalization in Ocular Myasthenia Gravis: A South Korean Cohort Study
T2 - Antibodies (Basel, Switzerland)
J2 - Antibodies (Basel)
PY - 2026
DA - 2026/08/11
VL - 15
IS - 4
SP - 73
SN - 2073-4468
PB - Multidisciplinary Digital Publishing Institute (MDPI)
DO - 10.3390/antib15040073
UR - https://doi.org/10.3390/antib15040073
LA - en
ER -

CSL-JSON

{
"id": "10.3390/antib15040073",
"type": "article-journal",
"title": "Acetylcholine Receptor Antibody Positivity, RNST Abnormality, and Thymoma Predict Generalization in Ocular Myasthenia Gravis: A South Korean Cohort Study",
"container-title": "Antibodies (Basel, Switzerland)",
"author": [
{
"family": "Shin",
"given": "Hyun Jin"
},
{
"family": "Kwon",
"given": "Chaerin"
},
{
"family": "Oh",
"given": "Jeeyoung"
}
],
"container-title-short": "Antibodies (Basel)",
"volume": "15",
"issue": "4",
"page": "73",
"DOI": "10.3390/antib15040073",
"PMID": "42645431",
"PMCID": "PMC13509972",
"ISSN": "2073-4468",
"publisher": "Multidisciplinary Digital Publishing Institute (MDPI)",
"URL": "https://doi.org/10.3390/antib15040073",
"language": "en",
"issued": {
"date-parts": [
[
2026,
8,
11
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1371/journal.pone.0346981
Comparative study of ocular and generalized myasthenia gravis in a South Korean cohort.
Journal: PloS one
In common: other condition, 9 references, author Hyun Jin Shin
[2] doi:10.1159/000552505
Successful Recovery from Life-Threatening Ventilatory Failure with Efgartigimod in Seronegative Myasthenia Gravis: Two Case Reports.
Journal: Case reports in neurology
In common: other condition, 2 references
[3] doi:10.1590/0004-282x-anp-2022-s105
Myasthenia gravis in clinical practice.
Journal: Arquivos de neuro-psiquiatria
In common: other condition, 2 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.